A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
In this image taken from video, an IV infusion is administered at Pure Alchemy Wellness in Chula Vista, Calif., in November 2025.
Javier Arciga/AP
hide caption
toggle caption
Javier Arciga/AP
The future of peptides in the US is about to become clearer. Here’s what you should know | CNN
FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies
Peptides May Soon Be Legal. These Companies Are Ready To Cash In
U.S. FDA panel to review 7 peptides amid growing popularity | CBC News
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
What's the deal with peptides? The hyped market under U.S. review
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
FDA Set To Review Safety And Access To Peptides: What You Need To Know
US panel backs trendy peptides despite safety concerns
Is a peptide boom underway? FDA advisers vote for looser rules
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave…
A little-known advisory group to the US Food and Drug Administration will meet this week to mull over whether to ease…
The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced…
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and…
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if…
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market…
